Cargando…

Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity

Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Holuka, Cyrielle, Snoeck, Chantal J., Mériaux, Sophie B., Ollert, Markus, Krüger, Rejko, Turner, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157140/
https://www.ncbi.nlm.nih.gov/pubmed/34067606
http://dx.doi.org/10.3390/jcm10102159
_version_ 1783699614434590720
author Holuka, Cyrielle
Snoeck, Chantal J.
Mériaux, Sophie B.
Ollert, Markus
Krüger, Rejko
Turner, Jonathan D.
author_facet Holuka, Cyrielle
Snoeck, Chantal J.
Mériaux, Sophie B.
Ollert, Markus
Krüger, Rejko
Turner, Jonathan D.
author_sort Holuka, Cyrielle
collection PubMed
description Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of the asymptomatic SARS-CoV-2 carriers are unknown. We used the CON-VINCE cohort of healthy, asymptomatic, and oligosymptomatic individuals that is statistically representative of the overall population of Luxembourg for age, gender, and residency to characterise this population. Gender (male), not smoking, and exposure to early-life or adult traumatic experiences increased the risk of IgA seropositivity, and the risk associated with early-life exposure was a dose-dependent metric, while some other known comorbidities of active COVID-19 do not impact it. As prior exposure to adversity is associated with negative psychobiological reactions to external stressors, we recorded psychological wellbeing during the study period. Exposure to traumatic events or concurrent autoimmune or rheumatic disease were associated with a worse evolution of anxiety and depressive symptoms throughout the lockdown period. The unique demographic profile of the “silent spreaders” highlights the role that the early-life period plays in determining our lifelong health trajectory and provides evidence that the developmental origins of health and disease is applicable to infectious diseases.
format Online
Article
Text
id pubmed-8157140
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81571402021-05-28 Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity Holuka, Cyrielle Snoeck, Chantal J. Mériaux, Sophie B. Ollert, Markus Krüger, Rejko Turner, Jonathan D. J Clin Med Article Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of the asymptomatic SARS-CoV-2 carriers are unknown. We used the CON-VINCE cohort of healthy, asymptomatic, and oligosymptomatic individuals that is statistically representative of the overall population of Luxembourg for age, gender, and residency to characterise this population. Gender (male), not smoking, and exposure to early-life or adult traumatic experiences increased the risk of IgA seropositivity, and the risk associated with early-life exposure was a dose-dependent metric, while some other known comorbidities of active COVID-19 do not impact it. As prior exposure to adversity is associated with negative psychobiological reactions to external stressors, we recorded psychological wellbeing during the study period. Exposure to traumatic events or concurrent autoimmune or rheumatic disease were associated with a worse evolution of anxiety and depressive symptoms throughout the lockdown period. The unique demographic profile of the “silent spreaders” highlights the role that the early-life period plays in determining our lifelong health trajectory and provides evidence that the developmental origins of health and disease is applicable to infectious diseases. MDPI 2021-05-17 /pmc/articles/PMC8157140/ /pubmed/34067606 http://dx.doi.org/10.3390/jcm10102159 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Holuka, Cyrielle
Snoeck, Chantal J.
Mériaux, Sophie B.
Ollert, Markus
Krüger, Rejko
Turner, Jonathan D.
Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
title Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
title_full Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
title_fullStr Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
title_full_unstemmed Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
title_short Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
title_sort adverse life trajectories are a risk factor for sars-cov-2 iga seropositivity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157140/
https://www.ncbi.nlm.nih.gov/pubmed/34067606
http://dx.doi.org/10.3390/jcm10102159
work_keys_str_mv AT holukacyrielle adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity
AT snoeckchantalj adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity
AT meriauxsophieb adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity
AT ollertmarkus adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity
AT krugerrejko adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity
AT turnerjonathand adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity
AT adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity